Trial Condition(s):

Meningitis, Meningococcal

Trial to evaluate the use of single dose ciprofloxacin vs rifampicin in the eradication of Neisseria meningitidis from close contacts of meningococcal meningitis cases

Bayer Identifier:

Trial_1258

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

1885

Trial Dates

August1990

November1991

Phase

Could I receive a placebo?

Products

Cipro (Ciprofloxacin hydrochloride, BAYO9867)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Meningitis, Meningococcal

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

2 Years

No Limit

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information